Trials / Completed
CompletedNCT06285474
Investigating LIFUP in Anhedonic Depression
Investigating Low Intensity Focused Ultrasound Pulsation (LIFUP) in Anhedonic Depression
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- University of California, Los Angeles · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will observe changes in brain imaging, behavior, and symptom measures following intervention with low intensity focused ultrasound pulsation (LIFUP) targeting reward circuitry in individuals who are depressed and anhedonic.
Detailed description
Participants will wear a provided Apple watch and download a study app to their personal phones in order for activity and phone use metrics to be collected. Participants will respond to weekly email surveys, daily ecological momentary assessment (EMA) surveys, complete computer-based neurocognitive assessments, undergo a baseline MRI scan with spectroscopy, receive 3 sessions of LIFUP sonication, undergo a follow up MRI with spectroscopy, then continue to be followed with surveys, neurocognitive assessment, and watch/phone data collection for 3 weeks after follow up MRI scan. Participants will be randomized 1:1 active:sham to receive LIFUP targeting the caudate head of the brain. Conditions will be double blinded so that neither participants nor investigators or research staff know if active or sham sonication is being administered.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Low Intensity Focused Ultrasound Pulsation (LIFUP) | All participants will undergo 3 identical LIFUP sessions. All sessions must occur at least 1 day apart, and no more than 3 days apart, such that sessions may occur at minimum on days 1, 3, 5 and at maximum may occur on days 1, 5, 9. |
Timeline
- Start date
- 2022-10-27
- Primary completion
- 2024-04-24
- Completion
- 2024-04-24
- First posted
- 2024-02-29
- Last updated
- 2025-01-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06285474. Inclusion in this directory is not an endorsement.